Breaking News

Today Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
EPZM Epizyme $10.40 0.1 (0.97%) 06:55 09/21/18 09/21 06:55 09/21/18 06:55 Recommendations	Epizyme analyst commentary at Citi » Citi opens 30 day… Citi opens 30 day catalyst watch for Epizyme. Citi analyst Robyn Karnauskas opened a 30 day catalyst watch for Epizyme in anticipation of an FDA decision on the partial hold on Tazemetostat. In the best case scenario, the analyst expects the partial hold to be lifted at the end of the 30 day period without any further delay. She notes that We note that Tazemetostat has been investigated in multiple indications, administered to 750 patients, and shown an overall positive safety profile with only a single case of secondary lymphoma. The analyst keeps a Buy rating on Epizyme. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	02 Oct

Saturday
ABBV AbbVie $95.69 -0.67 (-0.70%) , AGIO Agios Pharmaceuticals $73.42 -1.085 (-1.46%) … 04:55 09/15/18 09/15 04:55 09/15/18 04:55 Conference/Events	Society of Hematologic Oncology to hold annual meeting » SOHO 2018: 6th Annual… SOHO 2018: 6th Annual Meeting will be held in Houston on September 12-15. ABBV AbbVie $95.69 -0.67 (-0.70%) AGIO Agios Pharmaceuticals $73.42 -1.085 (-1.46%) ALXN Alexion $118.19 -0.84 (-0.71%) AMGN Amgen $200.54 -2.4 (-1.18%) AZN AstraZeneca $37.45 -0.17 (-0.45%) BAYRY Bayer $0.00 (0.00%) BMY Bristol-Myers $60.69 -0.11 (-0.18%) CELG Celgene $87.18 -1.57 (-1.77%) DNA Bought by RHHBY $0.00 (0.00%) EPZM Epizyme $10.15 -0.05 (-0.49%) GILD Gilead $73.38 -0.73 (-0.99%) INCY Incyte $68.10 0.63 (0.93%) JAZZ Jazz Pharmaceuticals $163.05 -2.17 (-1.31%) KPTI Karyopharm $18.71 -0.15 (-0.80%) LOXO Loxo Oncology $163.97 -1.38 (-0.83%) MRK Merck $69.98 -0.4 (-0.57%) NVS Novartis $85.26 -0.05 (-0.06%) PFE Pfizer $42.97 0.11 (0.26%) SGEN Seattle Genetics $78.22 1.02 (1.32%) SHPG Shire $177.31 4.93 (2.86%) SNSS Sunesis $1.86 -0.08 (-4.12%) TEVA Teva $22.84 0.63 (2.84%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 Sep 16 Sep 18 Sep 18 Sep 20 Sep 20 Sep 23 Sep 26 Sep 01 Oct 02 Oct 03 Oct 10 Oct 17 Oct 22 Oct 23 Oct 25 Oct 27 Oct 29 Oct 09 Nov 26 Nov 27 Nov 20 Dec 21 Dec 11 Jan 16 Feb 18 Feb

Over a week ago
ABBV AbbVie $96.36 3.11 (3.34%) , AGIO Agios Pharmaceuticals $74.50 0.33 (0.44%) … 04:55 09/14/18 09/14 04:55 09/14/18 04:55 Conference/Events	Society of Hematologic Oncology to hold annual meeting » SOHO 2018: 6th Annual… SOHO 2018: 6th Annual Meeting will be held in Houston on September 12-15. ABBV AbbVie $96.36 3.11 (3.34%) AGIO Agios Pharmaceuticals $74.50 0.33 (0.44%) ALXN Alexion $119.03 0.8 (0.68%) AMGN Amgen $202.94 3.44 (1.72%) AZN AstraZeneca $37.62 -0.265 (-0.70%) BAYRY Bayer $0.00 (0.00%) BMY Bristol-Myers $60.80 0.48 (0.80%) CELG Celgene $88.75 1.95 (2.25%) DNA Bought by RHHBY $0.00 (0.00%) EPZM Epizyme $10.20 0.45 (4.62%) GILD Gilead $74.11 0.7 (0.95%) INCY Incyte $67.47 0.93 (1.40%) JAZZ Jazz Pharmaceuticals $165.22 -0.64 (-0.39%) KPTI Karyopharm $18.86 0.25 (1.34%) LOXO Loxo Oncology $165.35 0.44 (0.27%) MRK Merck $70.86 1.01 (1.45%) NVS Novartis $85.31 0.88 (1.04%) PFE Pfizer $42.86 0.46 (1.08%) SGEN Seattle Genetics $77.20 0.19 (0.25%) SHPG Shire $172.38 -0.39 (-0.23%) SNSS Sunesis $1.94 -0.09 (-4.43%) TEVA Teva $22.21 0.01 (0.05%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Sep 15 Sep 16 Sep 18 Sep 18 Sep 20 Sep 20 Sep 23 Sep 26 Sep 02 Oct 03 Oct 10 Oct 17 Oct 22 Oct 23 Oct 25 Oct 27 Oct 29 Oct 09 Nov 26 Nov 27 Nov 20 Dec 21 Dec 11 Jan 16 Feb 18 Feb
ABBV AbbVie $93.25 0.05 (0.05%) , AGIO Agios Pharmaceuticals $74.17 1.75 (2.42%) … 04:55 09/13/18 09/13 04:55 09/13/18 04:55 Conference/Events	Society of Hematologic Oncology to hold annual meeting » SOHO 2018: 6th Annual… SOHO 2018: 6th Annual Meeting will be held in Houston on September 12-15. ABBV AbbVie $93.25 0.05 (0.05%) AGIO Agios Pharmaceuticals $74.17 1.75 (2.42%) ALXN Alexion $118.23 0.73 (0.62%) AMGN Amgen $199.50 -0.01 (-0.01%) AZN AstraZeneca $37.89 -0.095 (-0.25%) BAYRY Bayer $0.00 (0.00%) BMY Bristol-Myers $60.32 -0.17 (-0.28%) CELG Celgene $86.80 -0.41 (-0.47%) DNA Bought by RHHBY $0.00 (0.00%) EPZM Epizyme $9.75 0.1 (1.04%) GILD Gilead $73.98 1.75 (2.42%) INCY Incyte $66.54 -0.3 (-0.45%) JAZZ Jazz Pharmaceuticals $165.86 0.12 (0.07%) KPTI Karyopharm $18.61 -1.14 (-5.77%) LOXO Loxo Oncology $164.91 -5.63 (-3.30%) MRK Merck $69.85 0.76 (1.10%) NVS Novartis $84.43 0.43 (0.51%) PFE Pfizer $42.40 0.09 (0.21%) SGEN Seattle Genetics $77.01 -1.38 (-1.76%) SHPG Shire $172.77 2.6 (1.53%) SNSS Sunesis $2.03 -0.01 (-0.49%) TEVA Teva $22.20 0.32 (1.46%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Sep 16 Sep 18 Sep 20 Sep 20 Sep 23 Sep 26 Sep 02 Oct 03 Oct 10 Oct 17 Oct 22 Oct 23 Oct 25 Oct 27 Oct 29 Oct 09 Nov 26 Nov 20 Dec 21 Dec 11 Jan 16 Feb 18 Feb
ABBV AbbVie $93.56 0.36 (0.39%) , AGIO Agios Pharmaceuticals $70.80 -1.62 (-2.24%) … 10:39 09/12/18 09/12 10:39 09/12/18 10:39 Conference/Events	Society of Hematologic Oncology to hold annual meeting » SOHO 2018: 6th Annual… SOHO 2018: 6th Annual Meeting will be held in Houston on September 12-15. ABBV AbbVie $93.56 0.36 (0.39%) AGIO Agios Pharmaceuticals $70.80 -1.62 (-2.24%) ALXN Alexion $117.50 (0.00%) AMGN Amgen $200.79 1.28 (0.64%) AZN AstraZeneca $37.81 -0.17 (-0.45%) BAYRY Bayer $0.00 (0.00%) BMY Bristol-Myers $60.48 -0.01 (-0.02%) CELG Celgene $87.06 -0.15 (-0.17%) DNA Bought by RHHBY $0.00 (0.00%) EPZM Epizyme $9.70 0.05 (0.52%) GILD Gilead $74.49 2.26 (3.13%) INCY Incyte $65.79 -1.05 (-1.57%) JAZZ Jazz Pharmaceuticals $164.81 -0.93 (-0.56%) KPTI Karyopharm $19.26 -0.49 (-2.48%) LOXO Loxo Oncology $168.08 -2.46 (-1.44%) MRK Merck $69.73 0.64 (0.93%) NVS Novartis $84.66 0.66 (0.79%) PFE Pfizer $42.70 0.385 (0.91%) SGEN Seattle Genetics $77.00 -1.39 (-1.77%) SHPG Shire $171.30 1.13 (0.66%) SNSS Sunesis $2.01 -0.03 (-1.47%) TEVA Teva $22.08 0.2 (0.91%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Sep 12 Sep 12 Sep 12 Sep 16 Sep 20 Sep 20 Sep 23 Sep 26 Sep 02 Oct 03 Oct 10 Oct 17 Oct 22 Oct 23 Oct 25 Oct 27 Oct 29 Oct 09 Nov 26 Nov 20 Dec 21 Dec 16 Feb 18 Feb

EPZM Epizyme $10.00 -0.7 (-6.54%) 07:40 09/07/18 09/07 07:40 09/07/18 07:40 Initiation	Epizyme initiated at Morgan Stanley » Epizyme resumed with an… Epizyme resumed with an Equal Weight at Morgan Stanley. Morgan Stanley analyst David Lebowitz resumed coverage of Epizyme with an Equal Weight rating and $12 price target, recommending investors stay on the sidelines despite tazemetostat's potential as the partial clinical hold imposed in April by the FDA clouds the timing and increases the level of risk for the drug. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Sep
LOXO Loxo Oncology $168.63 1.18 (0.70%) , BLUE Bluebird Bio $160.95 -3.9 (-2.37%) … 04:55 09/06/18 09/06 04:55 09/06/18 04:55 Conference/Events	Citigroup to hold a conference » 13th Annual Biotech… 13th Annual Biotech Conference will be held in Boston on September 5-6. LOXO Loxo Oncology $168.63 1.18 (0.70%) BLUE Bluebird Bio $160.95 -3.9 (-2.37%) TSRO Tesaro $34.93 -0.82 (-2.29%) CRSP Crispr Therapeutics $53.46 -1.06 (-1.94%) NTLA Intellia Therapeutics $30.07 -0.69 (-2.24%) EPZM Epizyme $10.70 -0.5 (-4.46%) RCUS Arcus Biosciences $13.17 -1.33 (-9.17%) BLCM Bellicum Pharmaceuticals $6.97 -0.1 (-1.41%) VKTX Viking Therapeutics $12.49 -0.545 (-4.18%) RCKT Rocket Pharmaceuticals $23.42 -0.23 (-0.97%) PTLA Portola Pharmaceuticals $29.65 0.29 (0.99%) MYOV Myovant Sciences $23.07 -2.01 (-8.01%) KPTI Karyopharm $20.96 0.19 (0.91%) INO Inovio $5.54 0.115 (2.12%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Sep 06 Sep 12 Sep 12 Sep 12 Sep 23 Sep 27 Sep 01 Oct 26 Nov 01 Dec
LOXO Loxo Oncology $167.45 -1.62 (-0.96%) , BLUE Bluebird Bio $164.85 -3.5 (-2.08%) … 07:33 09/05/18 09/05 07:33 09/05/18 07:33 Conference/Events	Citigroup to hold a conference » 13th Annual Biotech… 13th Annual Biotech Conference will be held in Boston on September 5-6. LOXO Loxo Oncology $167.45 -1.62 (-0.96%) BLUE Bluebird Bio $164.85 -3.5 (-2.08%) TSRO Tesaro $35.75 3.28 (10.10%) CRSP Crispr Therapeutics $54.52 -2.08 (-3.67%) NTLA Intellia Therapeutics $30.76 -0.18 (-0.58%) EPZM Epizyme $11.20 -0.6 (-5.08%) RCUS Arcus Biosciences $14.50 0.11 (0.76%) BLCM Bellicum Pharmaceuticals $7.07 -0.15 (-2.08%) VKTX Viking Therapeutics $13.03 -0.03 (-0.23%) RCKT Rocket Pharmaceuticals $23.65 -0.2 (-0.84%) PTLA Portola Pharmaceuticals $29.36 -0.52 (-1.74%) MYOV Myovant Sciences $25.08 0.825 (3.40%) KPTI Karyopharm $20.77 -0.27 (-1.28%) INO Inovio $5.43 0.165 (3.14%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Sep 05 Sep 05 Sep 05 Sep 12 Sep 12 Sep 12 Sep 23 Sep 27 Sep 01 Oct 26 Nov 01 Dec

Over a month ago
EPZM Epizyme $9.90 -3.15 (-24.14%) 07:56 08/03/18 08/03 07:56 08/03/18 07:56 Recommendations	Epizyme analyst commentary at Jefferies » Epizyme looks oversold… Epizyme looks oversold after yesterday's pullback, says Jefferies. Jefferies analyst Michael Yee attributes the selloff yesterday in shares of Epizyme to the delay and push-out of the new drug application to the first half of 2019 and uncertainty around the partial clinical hold. The stock is becoming more of a "2019 play" for the NDA filing and full EZH2 data, Yee tells investors in a research note. Over the short term, the analyst views the stock as oversold and thinks it will bounce back on removing the clinical hold over the next two months. Yee keeps a Buy rating on Epizyme and lowered his price target for the shares to $22 from $27. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EPZM Epizyme $13.05 0.15 (1.16%) 07:10 08/02/18 08/02 07:10 08/02/18 07:10 Earnings	Epizyme reports Q2 EPS (42c), consensus (51c) » Reports Q2 revenue $12M,… Reports Q2 revenue $12M, consensus $540,000. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	02 Aug

On The Fly

News and insights, exclusive to thefly.com

16:10	Fly Intel: Wall Street's top stories for Friday»
13:26	On The Fly: Weekly technical notes for Russell 2000»
13:25	On The Fly: Weekly technical notes for S&P 500»
12:26	Fly Intel: Wall Street's top stories at midday»
12:17	On The Fly: ETF fund flow highlights»

View all On The Fly Stories »

Upcoming
Events (10)

UROV	Urovant Sciences - UROV
ARCE	Arco Platform - ARCE
	Five Federal Agencies Approve Amendments to Swap Margin Rule
JPM ...	2nd Annual Wealth Management Conference
	18th Congress of EURETINA
	13th Annual Real Estate Conference
	China Ag Trip
NTRS ...	GI2: Global Innovation Institute
	7th Annual Workiva User Conference
ARGO ...	Excess & Surplus/Specialty Insurance Seminar

View all of today’s events »

Today’s
Syndicate (0)

No syndicate deals for your search.

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial